Internal Medicine, Hematology & Oncology · Forest Hills, NY
NPI
1043424542
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
9610 Metropolitan Ave
Forest Hills, NY, 11375
Phone (718) 459-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$436K
26,310 services
Medicare patients, 2024
265
Average age 75
Drug cost, 2024
$8.6M
1,490 prescriptions
Company payments, 2025
$41.2
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David B Askin was code J1756 (injection, iron sucrose, 1 mg), 9,800 times for 17 patients. In total David B Askin billed 26,310 services in 125 codes, and Medicare paid $436K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 9,800 | 17 | $0.17 | $1,644 |
| 88185 Surgical Pathology Examination | Office | 693 | 30 | $21.34 | $15K |
| 36415 Venipuncture Blood Collection | Office | 626 | 230 | $8.64 | $5,407 |
| 85025 Blood Count | Office | 590 | 227 | $7.59 | $4,475 |
| 99214 Office E&M - Established | Office | 390 | 177 | $105.50 | $41K |
| 82728 Clinical Chemistry | Office | 318 | 186 | $13.28 | $4,223 |
| 83550 Clinical Chemistry | Office | 317 | 186 | $8.52 | $2,700 |
| 83540 Clinical Chemistry | Office | 317 | 185 | $6.30 | $1,998 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 315 | 76 | $51.32 | $16K |
| 83521 Immunoassay | Office | 272 | 94 | $16.93 | $4,604 |
| 82607 Clinical Chemistry | Office | 258 | 166 | $14.67 | $3,785 |
| 83615 Clinical Chemistry | Office | 203 | 138 | $5.89 | $1,196 |
| 80053 Clinical Chemistry | Office | 200 | 121 | $10.35 | $2,070 |
| 84165 Clinical Chemistry | Office | 138 | 95 | $10.53 | $1,453 |
| 86334 Immunoassay | Office | 137 | 94 | $21.89 | $2,999 |
By year: 2022 $374K for 32,095 services; 2023 $411K for 42,223 services; 2024 $436K for 26,310 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 693 | 30 | $21.34 | $15K |
| 36415 Venipuncture Blood Collection | 626 | 230 | $8.64 | $5,407 |
| 85025 Blood Count | 590 | 227 | $7.59 | $4,475 |
| 82728 Clinical Chemistry | 318 | 186 | $13.28 | $4,223 |
| 83550 Clinical Chemistry | 317 | 186 | $8.52 | $2,700 |
| 83540 Clinical Chemistry | 317 | 185 | $6.30 | $1,998 |
| 83521 Immunoassay | 272 | 94 | $16.93 | $4,604 |
| 82607 Clinical Chemistry | 258 | 166 | $14.67 | $3,785 |
| 83615 Clinical Chemistry | 203 | 138 | $5.89 | $1,196 |
| 80053 Clinical Chemistry | 200 | 121 | $10.35 | $2,070 |
Medicare prescription drug claims, 2024
In 2024, the drug David B Askin prescribed most often to Medicare patients was Prednisone, with 112 prescriptions and refills. In total David B Askin wrote 1,490 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 112 | 141 | 22 | $859 |
| Lupron Depot Leuprolide Acetate | 111 | 301 | 35 | $586K |
| Abiraterone Acetate Generic | 102 | 114 | 15 | $238K |
| Nubeqa Darolutamide | 94 | 94 | 13 | $1.3M |
| Procrit Epoetin Alfa | 89 | 89 | 24 | $178K |
| Aranesp Darbepoetin Alfa In Polysorbat | 80 | 80 | 26 | $266K |
| Xtandi Enzalutamide | 76 | 76 | 16 | $1.1M |
| Xgeva Denosumab | 67 | 75 | 17 | $204K |
| Eliquis Apixaban | 65 | 161 | 27 | $91K |
| Letrozole Generic | 62 | 186 | 20 | $1,068 |
| Erleada Apalutamide | 45 | 61 | Under 11 | $891K |
| Revlimid Lenalidomide | 43 | 43 | Under 11 | $569K |
| Orgovyx Relugolix | 41 | 41 | Under 11 | $107K |
| Akynzeo Fosnetupitant/Palonosetron | 40 | 40 | Under 11 | $30K |
| Hydroxyurea Generic | 34 | 91 | Under 11 | $770 |
Brand drugs: 964 claims; generic drugs: 526 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David B Askin $41.2 ($41.2 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $41.2.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $41.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.